We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

New Tool Identifies Novel Compound Targeting Causes of Type 2 Diabetes

News   Jun 25, 2015

 
New Tool Identifies Novel Compound Targeting Causes of Type 2 Diabetes
 
 
Advertisement
 

RELATED ARTICLES

AI Predicts Which Immune Key Opens Which Lock

News

A new artificial intelligence method means researchers can now link immune cells to their targets and for example uncouple which white blood cells recognize SARS-CoV-2. The developed tool has broad applications in understanding the function of immune system in infections, autoimmune disorders and cancer.

READ MORE

Large Clinical Trial To Test Polyclonal Antibody Therapeutic for COVID-19

News

A trial evaluating a new fully-human polyclonal antibody therapeutic targeted to SARS-CoV-2, called SAB-185, has begun enrolling non-hospitalized people with mild or moderate cases of COVID-19.

READ MORE

Silica Sponges Stimulate the Immune System

News

In order to increase immunotherapy precision and limit undesirable side effects, a team has developed silica nanoparticles with a very precise opening mechanism that can transport a drug exactly to where it should act. These microscopic vehicles could possibly be used not just for cancer treatment, but also to deliver other drugs at the very heart of our immune system, thus paving the way for entirely new therapeutic or preventive strategies.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cell Science Diagnostics Proteomics & Metabolomics Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE